Get started
Live feed
·
INSIDERFilingvia Quantisnow
Atea Pharmaceuticals Inc. logo

Amendment: Director Murphy Polly A. bought $25,446 worth of shares (6,100 units at $4.17), increasing direct ownership by 7% to 92,145 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
AVIRAtea Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AVIR (Atea Pharmaceuticals Inc.) and more on Quantisnow.